Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Inappropriate GH Secretion Syndrome (Acromegaly)

fluorodeoxyglucose f18 has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maiza, JC; Revel, C1
Giubbini, R; Giustina, A; Mazziotti, G1
Balcerzyk, M; Cano, DA; Castaño, JP; Fernandez-Maza, L; Ibañez-Costa, A; Leal-Campanario, R; Leal-Cerro, A; Luque, RM; Martín-Rodríguez, JF; Muñoz-Bravo, JL; Soto-Moreno, A; Venegas-Moreno, E1
Maiza, JC; Revel, C; Schneebeli, S; Zunic, P1
Hasegawa, S; Hirata, M; Hori, M; Nishimura, T; Tokita, N; Yamaguchi, H; Yoshioka, J1

Other Studies

5 other study(ies) available for fluorodeoxyglucose f18 and Inappropriate GH Secretion Syndrome (Acromegaly)

ArticleYear
Evolution of (18)FDG pituitary uptake after medical control of acromegaly.
    Pituitary, 2014, Volume: 17, Issue:3

    Topics: Acromegaly; Adenoma; Fluorodeoxyglucose F18; Hormone Antagonists; Humans; Pituitary Gland; Pituitary Neoplasms; Plasmacytoma; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin

2014
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field?
    Nuclear medicine communications, 2014, Volume: 35, Issue:9

    Topics: Acromegaly; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals

2014
Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly.
    Scientific reports, 2015, Nov-09, Volume: 5

    Topics: Acromegaly; Animals; Cell Cycle; Cellular Senescence; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Growth Hormone; Growth Hormone-Secreting Pituitary Adenoma; Phenotype; Positron-Emission Tomography; Rats; Tomography, X-Ray Computed; Tumor Cells, Cultured

2015
Acromegaly revealed by 18FDG-PET/CT in a plasmocytoma patient.
    Pituitary, 2012, Volume: 15, Issue:4

    Topics: Acromegaly; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plasmacytoma; Positron-Emission Tomography; Radiography; Tomography, Emission-Computed

2012
Fluorine-18 FDG myocardial positron emission tomographic findings before and after pituitary adenoma resection in a patient with acromegalic cardiomyopathy.
    Clinical nuclear medicine, 2000, Volume: 25, Issue:8

    Topics: Acromegaly; Adenoma; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Fluorodeoxyglucose F18; Follow-Up Studies; Gated Blood-Pool Imaging; Glucose; Heart; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Myocardium; Pituitary Neoplasms; Preoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Ventricular Function, Left

2000